We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

October 5, 2023

Tess’ Top Takes from this Month’s Meetings in Digital Health: September 2023

Commentary
Tessy Huss

Tess’ Top Takes from this Month’s Meetings in Digital Health: September 2023

It's been another month of great events at HealthXL, with topics ranging from Pharma 3.0 and how to do digital health better, to the role of medical affairs in the age of digitalisation.

To make sure you don't miss the top insights from our community meetings, here are my top six takeaways from HealthXL meetings that took place over the past two months: 

1. Digital Biomarkers in Neurology: Early Diagnosis & Disease Management

In this roundtable led by John Cohen from Johns Hopkins Applied Physics Lab, participants discussed how digital biomarkers could revolutionise neurology by providing authentic insights into patient daily activity and fostering patient trust for self-management.

Passively collecting data from patients using wearable devices and smart sensors is a reliable way to understand their daily activities. This method reduces the chance of patients changing their behaviour when they know they are being monitored. To use these digital biomarkers in clinical trials, it is important to validate the accuracy and effectiveness of the sensors and tools before life science companies start using them. In the field of neurology, the adoption of digital biomarkers in clinical care has been limited because there is no established way to get reimbursed for using them.

For patients with psychiatric or neurodegenerative disorders who may experience heightened paranoia or anxiety, it is critical to build trust in monitoring technologies. Additionally, digital biomarkers have shown promise in detecting and managing diseases in neurology. For instance, new tools like eye-tracking and facial biomarkers can assess the risk of developing a disease early on and analyse how effective the treatments are. 

In the future, a combined approach that includes both passive and active data collection is expected. The ultimate goal is to empower patients to manage their conditions on their own. 

Read the key discussion points here!

2. Masterclass: Multi-Condition SaMD: Regulatory Requirements and Future Implications

In this masterclass, Arrash Yassaee and Mani Shanmugham shared their experiences and challenges with getting Huma’s platform approved as the first agnostic SaMD platform. They emphasised the importance of approaching SaMD from an agnostic perspective, structuring and presenting data effectively, and navigating regulatory landscapes with an evidence-based strategy. 

Why consider an agnostic problem?

Building a robust technical file submission:

Evidence generation requirement:

Geographical differences in regulation: 

Dive deeper into this topic here.

3. MedTech : New revenue opportunities with digital, data and connectivity

MedTech has the potential to shape the future of healthcare by leveraging data, relevant skills, shorter product iteration cycles, software technology, physician touchpoints, and trust profiles.

Smaller, agile MedTech companies may have a more influential role compared to traditional players, transitioning from vendors to enablers by connecting devices and leveraging data. Overcoming challenges in infrastructure and aligning buyers and users require investment infrastructure, skills, and innovative business models. 

Sharing real-world information and making evidence-driven decisions are crucial in healthcare, addressing the issue of information silos and prioritising solution and outcome-centric approaches. AI and ML play a significant role in driving better product development and outcomes in healthcare, with challenges in monetising healthcare data. 

Differentiating between analytics, AL and ML in healthcare is important, addressing data quality, trust, and regulatory challenges. Concerns around adoption, usability, value creation, data integration, legal considerations, and reimbursement were highlighted as key factors for successful implementation. 

Dive deeper into this topic by reading the key takeaways here.

4. Pharma's Role in Remote Patient Monitoring in Oncology

Remote patient monitoring (RPM) solutions in oncology offer immense benefits for patients, health systems, and the pharmaceutical industry. These solutions can enhance treatment accessibility and improve medication adherence for patients. They also play a vital role in driving patient retention and improving risk profiles in clinical trials. 

However, the successful adoption of RPM tools depends on effective engagement with healthcare providers and patients. Additionally, RPM systems can expedite patient discharges and reduce readmission rates, thus benefiting healthcare systems. Despite their potential, implementing RPM solutions outside of clinical trials poses challenges related to regulation and commercialisation strategies. 

It is worth noting that the return on investment (ROI) of RPM solutions may primarily favour healthcare systems rather than pharmaceutical companies. Nonetheless, RPM offers opportunities to decrease the need for physical presence in clinical trials and support diverse patient populations. Moreover, pharmaceutical companies can leverage RPM data for drug discovery and research. However, ethical questions arise regarding patient consent and their willingness to participate in data collection endeavours. 

Discover other key takeaways and strategies to effectively navigate RPM in the digital landscape here

5. Masterclass : Effective Strategies for DTx Clinical Trial Design 

Proving clinical efficacy is crucial for digital therapeutics (DTx) companies to gain support from prescribers, users and buyers. Here are some key strategies discussed in the masterclass session on DTx clinical trial design:

By implementing these strategies, DTx companies can enhance their clinical trial design and effectively demonstrate the efficacy of their digital therapeutics. 

Dive deeper into this topic here.

These are just a few top takeaways from some of our discussions this month. Apply to attend an upcoming HealthXL Community event and get all the insights first hand. 

Join the HXL community, where  members can revisit, rewatch our webinars, read the key takeaways from virtual and in-person events and rewatch our webinars., and more. 

To round out our spotlight series on medical affairs in digital health, we’ve launched our latest HealthXL report: Pharma Medical Affairs: Digital Health’s Next Strategic Enabler.

See you in a HealthXL meeting soon!

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

No upcoming Virtual Events scheduled. Please check back again soon.

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

22 MAY 2024 @ 11AM ET

Masterclass: Drug discovery in AI for novel therapies - headwinds and tailwinds for investors

Please bear with us, this meeting is under construction. More details will follow shortly.
Martin Gershon
Featuring
Martin Gershon
Founder, Endeavor
23rd May 2024 @ 11am ET

Masterclass: Transforming Obesity Management: Digital Solutions vs. GLP-1 Blockbusters

In the world of obesity management, the clash between traditional medications like GLP-1 receptor agonists and modern digital health solutions is a trending topic.

Yury Rozenman
Featuring
Yury Rozenman
Senior Vice President Business Development, Propeller Health
28th May 2024 @ 11am ET

Health is Wealth in Hindsight: Leveraging Digital Health for Prevention

Digital health is emerging as a powerful ally in the realm of preventive healthcare, reshaping the landscape by offering innovative solutions and transformative strategies.

Kate O'Reilly
Featuring
Kate O'Reilly
Manager, Health & Life Sciences, EY
29th May 2024 @ 11am ET

What Does Innovation Look Like in Neurodegenerative Diseases?

Digital health technologies hold potential to revolutionise the patient journey in neurodegenerative disease, from early detection to ongoing management and support.

Ciara Clancy
Featuring
Ciara Clancy
Founder & CEO, Beats Medical Ltd

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.